Regulatory bodies approved GLP-1 receptor agonists are TRULICITY (dulaglutide), BYETTA/BYDUREON (exenatide), VICTOZA (liraglutide), OZEMPIC/WEGOVY/RYBELSUS, (Semaglutide), MOUNJARO/ZEPBOUND (tirzepatide) and others
Post SM, Stock ML, Persky S
doi: 10.4103/0972-6691.116608 Jain, S., Parsanathan, R., Achari, A., Kanikarla-Marie, P., & Bocchini, J
(PubMed) Virtamo J, Taylor PR, Kontto J, et al
After excluding all but the best-designed studies, they were left with 49 reports to include in their analysis
The trial used a flexible dosing protocol, permitting investigators to adjust doses based on individual tolerability and clinical judgement